SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CEPH -- Ignore unavailable to you. Want to Upgrade?


To: DOLLAR BILL who wrote (862)2/1/1999 12:11:00 AM
From: LLCF  Read Replies (1) | Respond to of 998
 
<If myotrophin is never approved. What do you think CEPH is worth as a one drug company? >

CEPH is a one drug company at this time... myotrophin is dead as far as I'm concerned, and as far as the street is concerned... thats already in the stock. What do I think it's worth? $16 share today...more if the pipeline shows more promise later. The company has a few bucks a share in cash, a product with LOTS of upside (IMO), and we'll see what happends with the 3 products in P2 and one product P1, and the rest.

DAK